BCYC Earnings

Quarterly EPS
$-0.74
Q3 2024
$-0.75
Q4 2024
$-0.88
Q1 2025
$-1.14
Q2 2025
$-0.85
Q3 2025
$-0.29
Q4 2025
$-0.87
Q1 2026
$-0.72
Q2 2026
Latest Revenue629.0K
Latest Net Income-50333000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.72629.0K-50333000-78.5%+36.8%
Q1 2026-$0.87887.0K-60825000-91.1%+1.1%
Q4 2025-$0.2948.0M-20154000+1,193.3%+61.3%
Q3 2025-$0.8511.7M-59100000+338.5%-14.9%
Q2 2025-$1.142.9M-78952000-68.8%-48.1%
Q1 2025-$0.8810.0M-60754000-48.9%-41.9%
Q4 2024-$0.753.7M-51854000-30.4%+34.8%
Q3 2024-$0.742.7M-50802000-50.0%+41.3%
Q2 2024-$0.779.4M-39812000
Q1 2024-$0.6219.5M-26563000
Q4 2023-$1.155.3M-49099000
Q3 2023-$1.265.4M-49898000
Bicycle Therapeutics plc American (BCYC) — Earnings